Nuvation Bio, Inc. (NUVB)
4.78
+0.03
(+0.63%)
USD |
NYSE |
May 29, 16:00
4.75
-0.03
(-0.63%)
Pre-Market: 20:00
Nuvation Bio Total Liabilities (Quarterly) : 290.68M for March 31, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| SIGA Technologies, Inc. | 67.77M |
| Merck & Co., Inc. | 82.75B |
| Pfizer Inc. | 117.21B |
| Harrow, Inc. | 391.19M |
| Alumis, Inc. | 104.57M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 610.24M |
| Shareholders Equity (Quarterly) | 319.56M |
| Debt to Equity Ratio | 0.679 |
| Current Ratio | 7.439 |
| Net Debt Paydown Yield | -2.79% |